vTv Therapeutics Profit Margin

The latest profit margin for VTVT is -12.92% as of June 2026. That compares with -115029.41% in the prior-year period — up 100.0% year over year. That is below the Healthcare sector average of 14.34%. Investors often review this figure alongside vTv Therapeutics's historical trend and sector peers before judging valuation or financial health.

Over the past year, VTVT's profit margin moved from -115029.41% to -12.92% — a 100.0% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in vTv Therapeutics's valuation or profitability profile.

Against Healthcare companies, VTVT currently prints -12.92% for profit margin, while the sector average sits near 14.34%. That is roughly 190.1% below the sector mean. Large gaps often invite a closer look at vTv Therapeutics's growth, margins, and balance sheet.

Profit Margin shows how effectively vTv Therapeutics converts resources into returns. At -12.92%, VTVT may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -115029.41% in the prior-year period — up 100.0% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting VTVT's profit margin (-12.92%), review year-over-year change from -115029.41%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.